During a clinical trial, it was reported that a patient underwent a repeat atrial fibrillation ablation procedure with an ez steer¿ bi-directional electrophysiology catheter on (b)(6) 2023 and suffered dyspnea.On (b)(6) 2023, patient experienced dyspnea categorized as severe and serious, categorized by serious deterioration in the health of the subject as defined by in-patient / prolonged hospitalization (admission date: (b)(6) 2023 and discharge date (b)(6) 2023) and medical or surgical intervention to prevent life-threatening illness or injury, or permanent impairment to a body structure or a body function.Relationship to study device is not related.The adverse event is expected/anticipated.The outcome is recovered/resolved.Intervention was medication and pacemaker re-programming.Device disposition was inserted and radio frequency was delivered.Additional information was provided on (b)(6) 2024.Relationship to repeat study procedure is possible.This event was originally considered non-reportable, however, bwi became aware that the relationship to the repeat study procedure is possible on (b)(6) 2024 and have reassessed the event as reportable.
|
E1.Initial reporter phone: (b)(4).Additional information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A device history review was performed for the finished device 30936131m number, and no internal actions related to the complaint were found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number:(b)(4).
|